Michael A. Weber - Concepedia

Author

Michael A. Weber

SUNY Downstate Health Sciences University ORCID

Also Known As

Asha Paireddy, Benno Eierle, Giuseppe Mancia, M A Weber, M WEBER, M Weber, M. A. J. Weber, M. A. Weber, M. Weber, M.A. Weber

826

Publications

44.9K

Citations

H-Index

218

Concepts

All Affiliations

SUNY Downstate Health Sciences University State University of New York University of California, Irvine University of Chicago Saarland University

About

Michael A. Weber is an author at SUNY Downstate Health Sciences University specializing in medicine, hypertension, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	63	164	19K
2	Public Health	31	45	8.7K
3	Health Sciences	10	10	434
4	Education	4	4	160
5	Engineering	3	3	322

Michael A. Weber

304

Publications

39.3K

Citations

H-Index

Page 1

	Year	Citations
Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events Deepak L. Bhatt, Keith A.A. Fox, Werner Hacke, New England Journal of Medicine	2006	2.8K
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial Stevo Julius, Sverre E. Kjeldsen, Michael A. Weber, The Lancet Non-pharmacological InterventionHypertensionCardiovascular DiseaseHealth PolicyHypertensive Patients	2004	2.5K
Hemodynamic Patterns of Age-Related Changes in Blood Pressure Stanley S. Franklin, William Gustin, Nathan D. Wong, Circulation	1997	2.3K
Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients Kenneth Jamerson, Michael A. Weber, George L. Bakris, New England Journal of Medicine	2008	2.1K
Clinical Practice Guidelines for the Management of Hypertension in the Community Michael A. Weber, Ernesto L. Schiffrin, William B. White, Journal of Clinical Hypertension HypertensionFasting SampleClinical Practice GuidelinesBlood PressureNon-pharmacological Intervention	2013	991
Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke Ralph L. Sacco, Hans‐Christoph Diener, Salim Yusuf, New England Journal of Medicine	2008	964
Feasibility of Treating Prehypertension with an Angiotensin-Receptor Blocker Stevo Julius, Shawna D. Nesbitt, Brent M. Egan, New England Journal of Medicine	2006	916
Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA Trial Deepak L. Bhatt, Marcus Flather, Werner Hacke, Journal of the American College of Cardiology Charisma TrialCardiovascular DiseasePrior Myocardial InfarctionMedicineArterial Disease Treatment	2007	799
Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events Salim Yusuf, Hans‐Christoph Diener, Ralph L. Sacco, New England Journal of Medicine	2008	773
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial David E. Kandzari, Michael Böhm, Felix Mahfoud, The Lancet HypertensionUrologyRenal FunctionAntihypertensive AgentsMedicine	2018	750

Page 1